Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease
Identifieur interne : 001411 ( Istex/Curation ); précédent : 001410; suivant : 001412Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease
Auteurs : Thanh G. Ton [États-Unis] ; Susan R. Heckbert [États-Unis] ; W. T. Longstreth Jr. [États-Unis] ; Mary Anne Rossing [États-Unis] ; Walter A. Kukull [États-Unis] ; Gary M. Franklin [États-Unis] ; Phillip D. Swanson [États-Unis] ; Terri Smith-Weller [États-Unis] ; Harvey Checkoway [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2006-07.
English descriptors
Abstract
Inflammation and oxidative stress have been implicated as pathogenic mechanisms in Parkinson's disease (PD). Evidence from in vitro and animal studies suggests a possible protective role of nonsteroidal anti‐inflammatory drugs (NSAIDs), including aspirin. We investigated the risk of PD associated with use of aspirin and nonaspirin NSAIDs in a population‐based case‐control study among enrollees of Group Health Cooperative, a health maintenance organization in the Seattle area. Subjects included 206 cases between ages 35 and 89 with a new diagnosis of idiopathic PD between 1992 and 2002, and 383 randomly selected controls frequency‐matched by age, sex, duration of enrollment, and clinic. We obtained information on participants' age, smoking, and medical history from interview. Exposure to NSAIDs was ascertained from an automated pharmacy database. Medications filled within 5 years of the interview were excluded. After adjusting for age, sex, smoking, duration of enrollment, and clinic, the risk of PD among individuals who received nonaspirin NSAIDs between 1977 and 1992 was 0.90 (95% CI: 0.59–1.35) and 1.67 (95% CI: 0.60–4.60) between 1993 and 2002. Use of ibuprofen was not associated with PD (OR: 0.89; 95% CI: 0.60–1.32). The risk of PD associated with aspirin or aspirin‐containing medications was 0.74 (95% CI: 0.49–1.12). We observed no trend in risk according to number of fills for these drugs. Our results provide only limited support for the hypothesis that use of aspirin may reduce the risk of this disease, and no indication of protection from other NSAIDs. © 2006 Movement Disorder Society
Url:
DOI: 10.1002/mds.20856
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001411
Links to Exploration step
ISTEX:D8CE3A218198D995E290A58653036C4A21D91D69Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease</title><author><name sortKey="Ton, Thanh G" sort="Ton, Thanh G" uniqKey="Ton T" first="Thanh G." last="Ton">Thanh G. Ton</name><affiliation wicri:level="1"><mods:affiliation>Department of Epidemiology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Heckbert, Susan R" sort="Heckbert, Susan R" uniqKey="Heckbert S" first="Susan R." last="Heckbert">Susan R. Heckbert</name><affiliation wicri:level="1"><mods:affiliation>Department of Epidemiology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Longstreth Jr, W T" sort="Longstreth Jr, W T" uniqKey="Longstreth Jr W" first="W. T." last="Longstreth Jr.">W. T. Longstreth Jr.</name><affiliation wicri:level="1"><mods:affiliation>Department of Epidemiology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Rossing, Mary Anne" sort="Rossing, Mary Anne" uniqKey="Rossing M" first="Mary Anne" last="Rossing">Mary Anne Rossing</name><affiliation wicri:level="1"><mods:affiliation>Department of Epidemiology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Kukull, Walter A" sort="Kukull, Walter A" uniqKey="Kukull W" first="Walter A." last="Kukull">Walter A. Kukull</name><affiliation wicri:level="1"><mods:affiliation>Department of Epidemiology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Franklin, Gary M" sort="Franklin, Gary M" uniqKey="Franklin G" first="Gary M." last="Franklin">Gary M. Franklin</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Environmental and Occupational Health Sciences, Seattle, University of Washington, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Environmental and Occupational Health Sciences, Seattle, University of Washington, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Swanson, Phillip D" sort="Swanson, Phillip D" uniqKey="Swanson P" first="Phillip D." last="Swanson">Phillip D. Swanson</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Smith Eller, Terri" sort="Smith Eller, Terri" uniqKey="Smith Eller T" first="Terri" last="Smith-Weller">Terri Smith-Weller</name><affiliation wicri:level="1"><mods:affiliation>Department of Environmental and Occupational Health Sciences, Seattle, University of Washington, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Environmental and Occupational Health Sciences, Seattle, University of Washington, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Checkoway, Harvey" sort="Checkoway, Harvey" uniqKey="Checkoway H" first="Harvey" last="Checkoway">Harvey Checkoway</name><affiliation wicri:level="1"><mods:affiliation>Department of Epidemiology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Environmental and Occupational Health Sciences, Seattle, University of Washington, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Environmental and Occupational Health Sciences, Seattle, University of Washington, Washington</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D8CE3A218198D995E290A58653036C4A21D91D69</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1002/mds.20856</idno><idno type="url">https://api.istex.fr/document/D8CE3A218198D995E290A58653036C4A21D91D69/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001411</idno><idno type="wicri:Area/Istex/Curation">001411</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease</title><author><name sortKey="Ton, Thanh G" sort="Ton, Thanh G" uniqKey="Ton T" first="Thanh G." last="Ton">Thanh G. Ton</name><affiliation wicri:level="1"><mods:affiliation>Department of Epidemiology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Heckbert, Susan R" sort="Heckbert, Susan R" uniqKey="Heckbert S" first="Susan R." last="Heckbert">Susan R. Heckbert</name><affiliation wicri:level="1"><mods:affiliation>Department of Epidemiology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Longstreth Jr, W T" sort="Longstreth Jr, W T" uniqKey="Longstreth Jr W" first="W. T." last="Longstreth Jr.">W. T. Longstreth Jr.</name><affiliation wicri:level="1"><mods:affiliation>Department of Epidemiology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Rossing, Mary Anne" sort="Rossing, Mary Anne" uniqKey="Rossing M" first="Mary Anne" last="Rossing">Mary Anne Rossing</name><affiliation wicri:level="1"><mods:affiliation>Department of Epidemiology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Kukull, Walter A" sort="Kukull, Walter A" uniqKey="Kukull W" first="Walter A." last="Kukull">Walter A. Kukull</name><affiliation wicri:level="1"><mods:affiliation>Department of Epidemiology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Franklin, Gary M" sort="Franklin, Gary M" uniqKey="Franklin G" first="Gary M." last="Franklin">Gary M. Franklin</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Environmental and Occupational Health Sciences, Seattle, University of Washington, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Environmental and Occupational Health Sciences, Seattle, University of Washington, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Swanson, Phillip D" sort="Swanson, Phillip D" uniqKey="Swanson P" first="Phillip D." last="Swanson">Phillip D. Swanson</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Smith Eller, Terri" sort="Smith Eller, Terri" uniqKey="Smith Eller T" first="Terri" last="Smith-Weller">Terri Smith-Weller</name><affiliation wicri:level="1"><mods:affiliation>Department of Environmental and Occupational Health Sciences, Seattle, University of Washington, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Environmental and Occupational Health Sciences, Seattle, University of Washington, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Checkoway, Harvey" sort="Checkoway, Harvey" uniqKey="Checkoway H" first="Harvey" last="Checkoway">Harvey Checkoway</name><affiliation wicri:level="1"><mods:affiliation>Department of Epidemiology, University of Washington, Seattle, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, University of Washington, Seattle, Washington</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Department of Environmental and Occupational Health Sciences, Seattle, University of Washington, Washington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Environmental and Occupational Health Sciences, Seattle, University of Washington, Washington</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2006-07">2006-07</date><biblScope unit="vol">21</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="964">964</biblScope><biblScope unit="page" to="969">969</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">D8CE3A218198D995E290A58653036C4A21D91D69</idno><idno type="DOI">10.1002/mds.20856</idno><idno type="ArticleID">MDS20856</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>NSAIDs</term><term>Parkinson's disease</term><term>aspirin</term><term>inflammation</term><term>nonsteroidal anti‐inflammatory drugs</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Inflammation and oxidative stress have been implicated as pathogenic mechanisms in Parkinson's disease (PD). Evidence from in vitro and animal studies suggests a possible protective role of nonsteroidal anti‐inflammatory drugs (NSAIDs), including aspirin. We investigated the risk of PD associated with use of aspirin and nonaspirin NSAIDs in a population‐based case‐control study among enrollees of Group Health Cooperative, a health maintenance organization in the Seattle area. Subjects included 206 cases between ages 35 and 89 with a new diagnosis of idiopathic PD between 1992 and 2002, and 383 randomly selected controls frequency‐matched by age, sex, duration of enrollment, and clinic. We obtained information on participants' age, smoking, and medical history from interview. Exposure to NSAIDs was ascertained from an automated pharmacy database. Medications filled within 5 years of the interview were excluded. After adjusting for age, sex, smoking, duration of enrollment, and clinic, the risk of PD among individuals who received nonaspirin NSAIDs between 1977 and 1992 was 0.90 (95% CI: 0.59–1.35) and 1.67 (95% CI: 0.60–4.60) between 1993 and 2002. Use of ibuprofen was not associated with PD (OR: 0.89; 95% CI: 0.60–1.32). The risk of PD associated with aspirin or aspirin‐containing medications was 0.74 (95% CI: 0.49–1.12). We observed no trend in risk according to number of fills for these drugs. Our results provide only limited support for the hypothesis that use of aspirin may reduce the risk of this disease, and no indication of protection from other NSAIDs. © 2006 Movement Disorder Society</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001411 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001411 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:D8CE3A218198D995E290A58653036C4A21D91D69
|texte= Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |